In 1983, Amgen scientists isolated the gene that creates EPO and filed a patent. Pioneering studies on erythropoietin were done by Dr. Joseph Eschbach and Dr. John Adamson at the University of Washington, and they found it could stimulate growth of oxygen-carrying red blood cells in sheep and correct anemia caused by kidney failure.